SALT LAKE CITY, December 5, 2024 – Varex Imaging Corporation (Nasdaq: VREX) is proud to introduce the LUMEN HD and LUMEN HD Pro digital radiography detectors, designed to meet
the evolving standards of healthcare imaging. As the demands of medical imaging continue to shift, these detectors are built to offer reliable, fast, and user-friendly performance in today’s
cost-conscious environment.
Key Features and Benefits:
– Reliable. The LUMEN family of detectors are designed for uninterrupted flow of the highest image quality, minimizing disruptions that can lead to lost revenue and compromised patient care.
– Faster. The LUMEN family is engineered for efficiency and rapid image production, to help patients get through the overall imaging workflow faster.
– Ease of Use. Featuring a lightweight and intuitive design, the LUMEN family’s tech-friendly design reduces burden on healthcare staff. Ergonomic handles, intuitive buttons, and a user-friendly interface streamline operation, making them more accessible.
– Configurable. Designed to adapt to your evolving imaging needs, the LUMEN family includes flexible system capabilities and customizable options that meet specialized requirements across various healthcare settings.
– Affordable. Competitively priced, the LUMEN family of detectors offers long-term value. Being configurable, they ensure you only pay for what you use, reducing long-term expenses.
As the landscape of healthcare continues to evolve, the LUMEN family is engineered to thrive in this new era. With advanced technology at their core, they meet the rigors and demands of modern imaging workflows, ensuring that healthcare providers can maintain efficiency and high standards of patient care.
For more information about the LUMEN HD and LUMEN HD Pro, please contact your Varex representative or the individuals listed below.
About Varex
Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices, and imaging software in their systems to detect, diagnose, protect, and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,300 people located in North America, Europe, and Asia. For more information visit vareximaging.com.
Forward Looking Statements
This news release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning product delivery, performance, and value; impact on the healthcare environment and workflow, as well as patient care; imaging needs; market acceptance of or transition to new products or technologies; financial results; and any statements using the terms “expect,” “can,” “could,” “may,” “intend,” “potential,” “designed,” and “possible” or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results and the outcome and timing of certain events to differ materially from those projected or management’s current expectations. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Varex assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.
# # #
For Investor Information Contact:
Christopher Belfiore
Director of Investor Relations
Varex Imaging Corporation
801.973.1566 | investors@vareximaging.com
For Sales Information, please visit Vareximaging.com and fill out our Contact form.
Articles
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2024
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2024.
VAREX SCHEDULES THIRD QUARTER FISCAL YEAR 2024 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2024 following the close of regular trading on Thursday, August 1, 2024.
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2024
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024.
VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION
Varex Imaging Corporation (Nasdaq: VREX) today announced it has entered into a senior secured revolving credit agreement (the “RLOC Facility”) for an initial aggregate principal amount of up to $155 million.
VAREX TO PRESENT AT OPPENHEIMER 34TH ANNUAL HEALTHCARE MEDTECH & SERVICES VIRTUAL CONFERENCE
Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference.
VAREX ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2024
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024.
VAREX SCHEDULES FIRST QUARTER FISCAL YEAR 2024 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2023 following the close of regular trading on Tuesday, November 14, 2023.
Varex Imaging to Present at the 6th Annual Evercore ISI HealthCONx Conference
Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the 6th Annual Evercore ISI HealthCONx Conference.
VAREX ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2023
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2023.